Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Utah Medical Products (UTMD) Return on Equity (2016 - 2025)

Utah Medical Products has reported Return on Equity over the past 15 years, most recently at 0.0% for Q4 2025.

  • Quarterly results put Return on Equity at 0.0% for Q4 2025, down 9.0% from a year ago — trailing twelve months through Dec 2025 was 0.0% (down 9.0% YoY), and the annual figure for FY2025 was 0.0%, down 9.0%.
  • Return on Equity for Q4 2025 was 0.0% at Utah Medical Products, down from 0.07% in the prior quarter.
  • Over the last five years, Return on Equity for UTMD hit a ceiling of 0.09% in Q3 2022 and a floor of 0.0% in Q4 2025.
  • Median Return on Equity over the past 5 years was 0.07% (2023), compared with a mean of 0.06%.
  • Biggest five-year swings in Return on Equity: increased 6bps in 2021 and later dropped -9bps in 2025.
  • Utah Medical Products' Return on Equity stood at 0.07% in 2021, then rose by 1bps to 0.07% in 2022, then crashed by -48bps to 0.04% in 2023, then skyrocketed by 123bps to 0.09% in 2024, then crashed by -105bps to 0.0% in 2025.
  • The last three reported values for Return on Equity were 0.0% (Q4 2025), 0.07% (Q3 2025), and 0.08% (Q2 2025) per Business Quant data.